Advanced Search
Li Aimin, Luo Rongcheng, Zhang Junyi, . The Study on the Treatment of the Malignant Tumor of Digestive Tract with 131I一CL3 in Tratumoral Injection Alone or Combined with LAK/IL-2 Intravenous Injection[J]. Cancer Research on Prevention and Treatment, 1999, 26(2): 123-124.
Citation: Li Aimin, Luo Rongcheng, Zhang Junyi, . The Study on the Treatment of the Malignant Tumor of Digestive Tract with 131I一CL3 in Tratumoral Injection Alone or Combined with LAK/IL-2 Intravenous Injection[J]. Cancer Research on Prevention and Treatment, 1999, 26(2): 123-124.
shu

The Study on the Treatment of the Malignant Tumor of Digestive Tract with 131I一CL3 in Tratumoral Injection Alone or Combined with LAK/IL-2 Intravenous Injection

  • Biotherapy and Research Center, Onmlogy Department, Nan Fang Hospital, Guang Zhou 510515

More Information
    Abstract
  • Purpose:To explore the affection of the LAK/IL-2 intavenous injection(LAK/IL-2 IV) to the therapeutic cfficay of the radioimmunothcrapy .Method:There were 72 patients with malignant tumor of digestive tract in this study, 21 patients recepting 131I-CL3 intratumoral injection alone(131I一CL3 IT)，33 patients recepting LAK/IL一2 IV alone, and 18 patient recepting 131I一IL3 IT conbined with LAK/IL一2IV. Result:The therapeutic efficay of 131I一CL3 IT alone or LAK/IL一2 IV alone. Conclusion:LAK/IL-2 IV can enhance the therapeutic efFicay of raclicoimmunotherapy.
    • FullText(HTML)
    • References (3)
  • [1]
    Fraker P,J,Speck ,JC.Protein and cell membrane iodintions with a sparingly soluble chlomamido 1,3,4,6-tetrnchlom-3α,Cradiphenyh gly-coluril.Biochem Biophys Res Commun, 1978, 80:849
    [2]
    曹雪涛主编.自细胞介素2的基础与临床，北京:科学技术出版社.1990,122
    [3]
    JolinWG,Claudio Du, Carol N, et al. Improved Radioimmuno-therapeutic efficacy of an anticarcinoma monoclonal antibody(1311-CC49)when given in combination with γ-interferon. Cancer res.1993, 53(Feb 1): 600
    • Related Articles

  • Related Articles

    [1]HAN Chun, BAI Li. Bottlenecks of Immune Checkpoint Inhibitors in Treatment of Gastrointestinal Tumors[J]. Cancer Research on Prevention and Treatment, 2025, 52(7): 539-547. DOI: 10.3971/j.issn.1000-8578.2025.24.1051
    [2]LI Menghan, XIAO Qiong, GAO Peng, FU Yu, SUN Chenrui, SONG Yongxi. LncRNA Prognostic Risk Scoring Model for Gastrointestinal Tumors Based on TCGA Database[J]. Cancer Research on Prevention and Treatment, 2022, 49(6): 606-611. DOI: 10.3971/j.issn.1000-8578.2022.21.1159
    [3]SI Yiran, YUE Jian, LIU Zhaoyang, LI Mo, ZHENG Yuanyi, WANG Xiaobing, YUAN Peng. Immune Mechanism of Tumor Cell Lysate Combined with IL-2 Preventing Melanoma and Inhibiting Tumor Growth[J]. Cancer Research on Prevention and Treatment, 2021, 48(2): 115-120. DOI: 10.3971/j.issn.1000-8578.2021.20.0606
    [4]YANG Qing, ZHANG Xiangmei, WENG Chengang, SHAN Baoen. Research Advances of IL-8 and Its Receptors in Tumor Progression and Treatment[J]. Cancer Research on Prevention and Treatment, 2019, 46(1): 81-84. DOI: 10.3971/j.issn.1000-8578.2019.18.0756
    [5]HAN Jie, LV Bing-rong, TAN Bi-bo, GENG Wei, WANG An-feng, ZHAO Jian-hui, HE Chun-nian. Relationship between Expression of survivin, bcl-2 and Chemosensitivities in Lymph Node Metastases Compared with Gastrointestinal Primary Tumor[J]. Cancer Research on Prevention and Treatment, 2009, 36(07): 571-574. DOI: 10.3971/j.issn.1000-8578.2009.07.009
    [6]LI Ai-min, LUO Rong-cheng, DING Xue-mei, et al, . The influence of the level of IL-2 in pleural fluid on the increasing rate and anti-tumor effect of TIL derived from malignant pleural fluid in vitro ReplaceChar('spanTitle')[J]. Cancer Research on Prevention and Treatment, 2003, 30(04): 276-277. DOI: 10.3971/j.issn.1000-8578.2261
    [7]ZENG Xing, MEI Yu-Ping, HUANG Yu, . Study on the Effect of rBCG-IL-2 on Anti-tumor Growth and Immunine Stimulation[J]. Cancer Research on Prevention and Treatment, 2000, 27(06): 425-426. DOI: 10.3971/j.issn.1000-8578.633
    [8]Zhang Yuegui, . Treatment of Patients with Advanced Malibnant Tumor by Transfor LAK Cells Combined with rIL-2[J]. Cancer Research on Prevention and Treatment, 1995, 22(1): 12-13.
    [10]Lu Jia qi, . ESTROGEN AND PROGESTERONE RECEPTOR IN MALIGNANT DIGESTIVE TRACT TUMOR[J]. Cancer Research on Prevention and Treatment, 1989, 16(2): 87-90.

Catalog

    Zhang Junyi

    • Biotherapy and Research Center, Onmlogy Department, Nan Fang Hospital, Guang Zhou 510515

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Get Citation
    PDF
    XML
    Article views (1599) PDF downloads (366) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Download Center

    Links

    Contact Us

    Address：116 Zhuodaoquan South Road,
    Hongshan District, Wuhan（430079）

    Tel：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits：22067448 Visits today：33097

    Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return